Article Listing - Xenon in $646 million deal with Roche unit

OPTIMIZATION OF GLOBAL R&D STRATEGY

20 April 1992

Because pharmaceutical development times contain, of necessity, prescribed periods which are of similar duration for competing innovator companies (eg long-term...

CIBA-GEIGY SPAIN PROFITS DOWN

20 April 1992

Net profits at the Spanish subsidiary of the Swiss chemical and pharmaceutical company Ciba-Geigy fell 43% in 1991 to around...

MERGER DENIALS BY CIBA-GEIGY

20 April 1992

Alex Krauer, managing director of the Swiss chemical and pharmaceutical concern, Ciba-Geigy, has denied that his company could be about...

US FDA USER FEE REG THIS MONTH?

20 April 1992

User fee legislation is currently being drafted by the US Food and Drug Administration and could be ready for submission...

US AIDS MARKET FORECASTS TO 1998

20 April 1992

The US market for products to diagnose, monitor and treat AIDS will grow from close to $300 million in 1991...

STREP PNEUMONIAE VACCINE IN DEV'T

20 April 1992

A new improved vaccine directed against the bacterium responsible for bacterial meningitis and various other infectious diseases, Streptococcus pneumoniae ,...

FIRST QTR RESULTS FROM DEPRENYL

20 April 1992

Canadian pharmaceutical company Deprenyl Research Ltd achieved revenues of C$2.8 million ($2.3 million) in the first quarter of 1992, an...

JOHN PETRICCIANI JOINS GENETICS INSTITUTE

20 April 1992

John Petricciani, previously vice president for medical and regulatory affairs as the US Pharmaceutical Manufacturers Association, has moved to Genetics...

US PATENT GRANTED FOR INHIBIN

20 April 1992

A US patent has been awarded to Biotech Australia with Monash University, Prince Henry's Institute of Medical Research and St...

CANGENE CANCER DRUG IN TRIALS?

20 April 1992

Canadian biotechnology concern Cangene has applied for permission from the Canadian government to begin clinical testing of leucotropin, the company's...

Showing 94481-94490 of 95579 articles